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 family comprises many cytokines involved
in the control of cell fate (1). Some of these have been
shown to control cell death. For instance, at least one of





required in interdigital death, a classical model of develop-









1, entertains a complicated relation-
ship with cell death, of lymphocytes in particular. When
added extracellularly, it has been reported to induce death
of B lymphocytes (3, 4) and to prevent T lymphocyte
death (5–7).
A new, and at times somewhat heretical twist, is now re-









1, W.J. Chen et al.
(8) found that apparently spontaneous apoptosis of both
thymic and peripheral T cells was increased compared with





1 had previously been shown to pre-
vent T cell death (see above). However, not only was
spontaneous T cell death impressive in both thymus and
peripheral organs, but results were even more striking
when T cells were challenged with anti-CD3 antibody
(mimicking stimulation through the TCR). In vitro exper-





1 knockout mice, resulting in marked activa-
tion-induced cell death. The most spectacular results were





1 knockout mice, leading to massive apoptosis in
both thymus and spleen, visible as terminal deoxynucleotidyl
transferase (TdT)-mediated dUTP-biotin nick end-label-
ing (TUNEL)-positive cells within hours, and effecting
considerable reduction in lymphoid organ cell numbers.
This was accompanied by an increase in expression of Fas
and Fas ligand in spleen cells, and increase in sensitivity to
the Fas pathway and in some situations to the TNFR2
pathway of cell death. These results demonstrated that acti-















 family, are known to
affect cells from the outside through cognate cell surface re-
ceptors, the engagement of which lead to intracellular acti-
vation of Smad transcription factors, especially Smad3 in




1 (1, 11, 12). However, the current









1. Two lines of evi-




 did not correct















nists, of which there are many (11). These are very efficient
blockers when added externally as shown in the interdigital
cell death model mentioned above (13, 14), and might be




1 knockout situation where















1 during suckling, while interestingly the apop-
totic T cell phenotype is not. Second, no sensitization to cell





was observed in mice inactivated for the Smad3 gene, ruling
out the participation of a Smad3 transduction pathway. In








 mice showed normal develop-
ment of lymphocytes and increased proliferation and acti-
vation of T cells (15) within an abnormal phenotype which












 (for a review,





1 acts not only extracellularly via its cognate re-
ceptor and Smad3, but also intracellularly. As an alterna-




1 might act only ex-
tracellularly via its cognate receptor but be able to use, say,
another Smad than Smad3 (16). Definitive arguments in fa-
vor of an “intracrine” mechanism similar to that of e.g., fi-
broblast growth factor 2 (17) may require, for instance, ret-












T cells with a construct









1 has an intracellular role suggests interest-





molecules, as a ligand for a cell-surface receptor, and as an
intracellularly active molecule, as well as two functions,
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aborting or triggering cell death. One wonders whether the




1 molecule would be used in both
instances.





may act intracellularly to protect cells from death, in the
very cells that most probably synthesize it. If protection is
intracellular, then where does it take place and how? Mito-
chondria involvement is appealing, since mitochondria are
considered integrators for programmed cell death (18, 19).




 can be found in
mitochondria (20, 21). This observation is now confirmed
and extended, using several techniques, such as organelle
fractionation followed by Western blot analyses and ELISA
tests, immunolocalization, and immunogold electron mi-
croscopy (8). What then could be the relationship between




, increased cell death




, and mitochondrial involvement in





1 knockout cells (8). Also, in dying wild-type
cells mitochondria show modifications of their membrane
potential, believed to be essential at least in some cases for
the release of several proapoptotic factors. Cell death in-




 also shows a decrease in
mitochondrial membrane potential (8). This is regulated by
members of the Bcl-2 family such as the antiapoptotic
Bcl–XL molecule. While in wild-type T cells costimulation





1 knockout T cells there is no such increase.





1 within mitochondria, they are only correla-
tive. In particular, it is difficult to understand what relation-





chondria and the level of Bcl–XL mRNA in the cytoplasm;





 receptors on Smad transcription factors.





hepatocyte apoptosis through the mitochondrial/Apaf-1
caspase activation pathway (22), downregulates Bcl-XL in a
rat prostate epithelial cell line which decreases its death
(23), and induces cell death in a variety of cell types in a
manner which is enhanced by the mitochondrially located




1 need not reside
within the mitochondria to induce cell death through a
Bcl–XL- and ARTS-regulated mitochondrial pathway.
True, compared with the work of Chen et al., the latter





 induced rather than inhibited cell death. In















 induces cell death by affecting mito-




 located in mitochondria





1, even if acting within the cell, ex-





 can indeed be located also in other
subcellular sites (21).





1 strongly protects T lymphocytes from
cell death and provides provocative results possibly assign-




1. It is tempting
to hypothesize that at least some of the protected cells are
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